Pakistan: Recent research published in the Cureus Journal has identified the platelet-to-lymphocyte ratio (PLR) as a reliable ...

Over the past decade, immunotherapy has revolutionized cancer treatment, improving the chance for cure and survival even for poor-prognosis tumors. Immune ...

The FDA has approved Emrelis to treat adults with locally advanced or metastatic NSCLC with high c-Met protein overexpression.

The antibody-drug conjugate is approved for previously treated advanced NSCLC patients with high c-Met protein overexpression ...

LIKE most of us, when Zee Valentina began feeling more tired than normal, she – and even her doctors – dismissed it as ...

Telisotuzumab vedotin (Teliso-V) gained FDA approval as a targeted therapy for patients with advanced non–small cell lung ...

A Ludwig Cancer Research study has identified a key mechanism by which advanced ovarian cancers suppress anti-tumor immune responses and resist immunotherapies.

The blood cancer market is experiencing robust growth, driven by rising incidence rates and advancements in targeted therapies and immuno-oncology. I ...